Pular para o conteúdo

Interações medicamentosas

Aprepitant + Cobimetinib

Gravidade: Grave

Aprepitant and Cobimetinib: major interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Aprepitant is a moderate CYP3A4 inhibitor and can raise cobimetinib concentrations. This increases the risk of cobimetinib toxicity such as rash, diarrhea, hemorrhage, liver injury and retinopathy.

O que esta interação significa em palavras simples

Aprepitant and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Aprepitant belongs to Gastrointestinal Tract; Cobimetinib belongs to Oncology.

Nível de evidência: Moderate

Por que acontece

Aprepitant inhibits CYP3A4, reducing the metabolism of cobimetinib, a CYP3A substrate.

O que fazer

Avoid the combination and use an alternative antiemetic. If short-term use is unavoidable, reduce cobimetinib to 20 mg daily as labeled and monitor closely for toxicity.

O que perguntar ao farmacêutico

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Aprepitant e Cobimetinib, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Aprepitant with Cobimetinib?

MediHelp rates the interaction as major. Aprepitant and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Aprepitant is a moderate CYP3A4 inhibitor and can raise cobimetinib concentrations. This increases the risk of cobimetinib toxicity such as rash, diarrhea, hemorrhage, liver injury and retinopathy.

How serious is the interaction between Aprepitant and Cobimetinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use an alternative antiemetic. If short-term use is unavoidable, reduce cobimetinib to 20 mg daily as labeled and monitor closely for toxicity.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar